TY - JOUR
T1 - Angiotensin II-Induced Oxidative Stress in Human Endothelial Cells
T2 - Modification of Cellular Molecules through Lipid Peroxidation
AU - Lee, Seon Hwa
AU - Fujioka, Shuhei
AU - Takahashi, Ryo
AU - Oe, Tomoyuki
N1 - Funding Information:
*E-mail: sh-lee@m.tohoku.ac.jp. Phone: +81-22-795-6818. *E-mail: t-oe@mail.pharm.tohoku.ac.jp. ORCID Seon Hwa Lee: 0000-0003-1095-5516 Tomoyuki Oe: 0000-0002-3893-0815 Present Addresses ‡S.F., Pharmaceutical Technology Division, Daiichi Sankyo Co. Ltd., 1−12−1 Shinomiya, Hiratsuka, Kanagawa 254−0014, Japan. §R.T., Kobe Pharmaceutical Research Center, Nippon Boehringer Ingelheim Co. Ltd., 6−7−5 minatojima-Minami-machi, Chuo-ku, Kobe, Hyogo 660−0047, Japan. Funding This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (to T.O., 15K14935 for 2015−2016), and Grants-in-Aid for Scientific Research (C) (to S.H.L., 16K08391 for 2016−2018) and (B) (to T.O., 16H05078 for 2016−2018) from the Japan Society for the Promotion of Science (JSPS). Notes The authors declare no competing financial interest.
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/7/15
Y1 - 2019/7/15
N2 - Angiotensin (Ang) II is a major bioactive peptide of the renin/angiotensin system and is involved in various cardiovascular functions and diseases. Ang II type 1 (AT1) receptor mediates most of the physiological effects of Ang II. Previous studies have revealed that the lipid peroxidation products 4-oxo-2(E)-nonenal (ONE) and 4-hydroxy-2(E)-nonenal (HNE) readily modify the N-terminus and Asp1, Arg2, and His6 residues of Ang II, and these modifications alter the biological activities of Ang II. Ang II is known to stimulate the formation of reactive oxygen species (ROS) that mediate cardiovascular remodeling. Another major consequence of ROS-derived damage is lipid peroxidation, which generates genotoxic aldehydes such as ONE and HNE. This study demonstrated that Ang II induced lipid peroxidation-derived modifications of cellular molecules in EA.hy926 cells, a human vascular endothelial cell line. Ang P (ONE- and ROS-derived N-terminal pyruvamide Ang II) and [His6(HNE)]-Ang II were detected in the medium of EA.hy926 cells incubated with Ang II, and their concentrations increased dose-dependently upon the addition of ascorbic acid (AscA) and CuSO4. Cells were then subjected to metabolic labeling using SILFAC (stable isotope labeling by fatty acids in cell culture) with [13C18]-linoleic acid. Analysis of cellular phospholipids indicated over 90% labeling. [13C9]-Thiadiazabicyclo-ONE-glutathione adduct as well as Ang P and [His6([13C9]-HNE)]-Ang II was detected in the labeled cells upon treatment with Ang II and their concentrations increased in an Ang II dose-dependent manner. Incubation of the labeled cells with losartan, an AT1 receptor blocker, inhibited the formation of modified Ang IIs in a dose-dependent manner. These results indicate that Ang II induces lipid peroxidation and modification of various cellular molecules and these reactions are mediated by the activation of AT1 receptor. Therefore, lipid peroxidation could be one mechanism by which Ang II contributes to cardiovascular dysfunction.
AB - Angiotensin (Ang) II is a major bioactive peptide of the renin/angiotensin system and is involved in various cardiovascular functions and diseases. Ang II type 1 (AT1) receptor mediates most of the physiological effects of Ang II. Previous studies have revealed that the lipid peroxidation products 4-oxo-2(E)-nonenal (ONE) and 4-hydroxy-2(E)-nonenal (HNE) readily modify the N-terminus and Asp1, Arg2, and His6 residues of Ang II, and these modifications alter the biological activities of Ang II. Ang II is known to stimulate the formation of reactive oxygen species (ROS) that mediate cardiovascular remodeling. Another major consequence of ROS-derived damage is lipid peroxidation, which generates genotoxic aldehydes such as ONE and HNE. This study demonstrated that Ang II induced lipid peroxidation-derived modifications of cellular molecules in EA.hy926 cells, a human vascular endothelial cell line. Ang P (ONE- and ROS-derived N-terminal pyruvamide Ang II) and [His6(HNE)]-Ang II were detected in the medium of EA.hy926 cells incubated with Ang II, and their concentrations increased dose-dependently upon the addition of ascorbic acid (AscA) and CuSO4. Cells were then subjected to metabolic labeling using SILFAC (stable isotope labeling by fatty acids in cell culture) with [13C18]-linoleic acid. Analysis of cellular phospholipids indicated over 90% labeling. [13C9]-Thiadiazabicyclo-ONE-glutathione adduct as well as Ang P and [His6([13C9]-HNE)]-Ang II was detected in the labeled cells upon treatment with Ang II and their concentrations increased in an Ang II dose-dependent manner. Incubation of the labeled cells with losartan, an AT1 receptor blocker, inhibited the formation of modified Ang IIs in a dose-dependent manner. These results indicate that Ang II induces lipid peroxidation and modification of various cellular molecules and these reactions are mediated by the activation of AT1 receptor. Therefore, lipid peroxidation could be one mechanism by which Ang II contributes to cardiovascular dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=85067915062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067915062&partnerID=8YFLogxK
U2 - 10.1021/acs.chemrestox.9b00110
DO - 10.1021/acs.chemrestox.9b00110
M3 - Article
C2 - 31144504
AN - SCOPUS:85067915062
SN - 0893-228X
VL - 32
SP - 1412
EP - 1422
JO - Chemical Research in Toxicology
JF - Chemical Research in Toxicology
IS - 7
ER -